Akcea Therapeutics Inc(NASDAQ:AKCA) stock News

AKCA Latest News, Press Relases and Analysis

All

Press Releases

5 years ago - By: Akcea Therapeutics, Inc.; Ionis Pharmaceuticals, Inc. - Mentions: IONS

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product

5 years ago - By: Ionis Pharmaceuticals, Inc. - Mentions: IONS

Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics

5 years ago - By: Zacks Investment Research - Mentions: BIIB IONS

Ionis' Alexander Disease Candidate Gets Orphan Drug Status

5 years ago - By: WeissLaw LLP - Mentions: IMMU

SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA, IMMU, and MXIM Shareholders About Its Ongoing Investigations

5 years ago - By: Halper Sadeh LLP - Mentions: CGIX BYFC BMCH

IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Is Investigating the Following Companies; Shareholders are Encouraged to Contact the Firm – CGIX, BYFC, BMCH, AKCA

5 years ago - By: Halper Sadeh LLP - Mentions: GILD CBMG VRTU IMMU

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, AKCA, VRTU, IMMU

5 years ago - By: Seeking Alpha - Mentions: IONS

Akcea's Waylivra secures NICE recommendation for ultra-rare inherited disorder (NASDAQ:AKCA)

5 years ago - By: Zacks Investment Research - Mentions: ALXN ALNY IONS

Alexion & Caelum Begin Studies on CAEL-101 in AL Amyloidosis

5 years ago - By: Halper Sadeh LLP - Mentions: AIMT PTI

ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – AIMT, AKCA, PTI

5 years ago - By: WeissLaw LLP - Mentions: AIMT

SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA and AIMT Shareholders About Its Ongoing Investigations

5 years ago - By: Kaskela Law LLC

Kaskela Law LLC Announces Stockholder Investigation of Akcea Therapeutics, Inc. (AKCA) and Encourages Investors to Contact the Firm

5 years ago - By: Kahn Swick & Foti, LLC

AKCEA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akcea Therapeutics, Inc. - AKCA

5 years ago - By: Monteverde & Associates PC

INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Akcea Therapeutics, Inc. - AKCA

5 years ago - By: Zacks Investment Research - Mentions: PFE NVS IONS

Ionis to Acquire Remaining Stake in Akcea, Stocks Rally

5 years ago - By: Benzinga - Mentions: WSC GLUU PRTS QCOM ...

Benzinga's Top Upgrades, Downgrades For September 1, 2020

5 years ago - By: Benzinga - Mentions: QCOM CMG SR NPTN ...

10 Biggest Price Target Changes For Tuesday

5 years ago - By: Johnson Fistel, LLP - Mentions: IONS

(AKCA) Alert: Johnson Fistel Investigates Proposed Sale of Akcea Therapeutics; Is $18.15 a Fair Price?

5 years ago - By: WeissLaw LLP - Mentions: IONS

SHAREHOLDER ALERT: WeissLaw LLP Investigates Akcea Therapeutics, Inc.

5 years ago - By: The Motley Fool - Mentions: IONS

Why Akcea Therapeutics Stock Skyrocketed Today

5 years ago - By: Seeking Alpha - Mentions: AIMT GNW HHT GME ...

GTX, GME, GNW and AIMT among midday movers

5 years ago - By: Seeking Alpha - Mentions: AIMT PDEX KIN STIM ...

Aimmune Therapeutics rallies on Nestle acquiring, Akcea cheers Ionis acquiring 24% remaining stake, ADiTx Therapeutics and Lipocine among major losers

5 years ago - By: Seeking Alpha - Mentions: IONS

Akcea shoots up 59% after Ionis acquires remaining stake for $500M; positive vupanorsen data reported (NASDAQ:AKCA)

5 years ago - By: Seeking Alpha - Mentions: IONS

Akcea Therapeutics Inc (AKCA) Stock News

AKCA Latest News, Press Relases and Analysis

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product

Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics

Ionis' Alexander Disease Candidate Gets Orphan Drug Status

SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA, IMMU, and MXIM Shareholders About Its Ongoing Investigations

IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Is Investigating the Following Companies; Shareholders are Encouraged to Contact the Firm – CGIX, BYFC, BMCH, AKCA

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, AKCA, VRTU, IMMU

Akcea's Waylivra secures NICE recommendation for ultra-rare inherited disorder (NASDAQ:AKCA)

Alexion & Caelum Begin Studies on CAEL-101 in AL Amyloidosis

ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – AIMT, AKCA, PTI

SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA and AIMT Shareholders About Its Ongoing Investigations

Kaskela Law LLC Announces Stockholder Investigation of Akcea Therapeutics, Inc. (AKCA) and Encourages Investors to Contact the Firm

AKCEA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akcea Therapeutics, Inc. - AKCA

INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Akcea Therapeutics, Inc. - AKCA

Ionis to Acquire Remaining Stake in Akcea, Stocks Rally

Benzinga's Top Upgrades, Downgrades For September 1, 2020

10 Biggest Price Target Changes For Tuesday

(AKCA) Alert: Johnson Fistel Investigates Proposed Sale of Akcea Therapeutics; Is $18.15 a Fair Price?

SHAREHOLDER ALERT: WeissLaw LLP Investigates Akcea Therapeutics, Inc.

Why Akcea Therapeutics Stock Skyrocketed Today

GTX, GME, GNW and AIMT among midday movers

Aimmune Therapeutics rallies on Nestle acquiring, Akcea cheers Ionis acquiring 24% remaining stake, ADiTx Therapeutics and Lipocine among major losers

Akcea shoots up 59% after Ionis acquires remaining stake for $500M; positive vupanorsen data reported (NASDAQ:AKCA)

Akcea shoots up 59% on positive vupanorsen data; Ionis acquires remaining stake for $500M (NASDAQ:AKCA)